Cerebellar mutism syndrome …

Benjamin I Siegel MD

Neuro-Oncology

Updated 04.29.2024
Released 11.13.2003
Expires For CME 04.29.2027

Cerebellar mutism syndrome

Author: Benjamin I Siegel MD

See Contributor Disclosures

Editor: Roger J Packer MD

Cerebellar mutism syndrome

In This Article

Quick Link

Introduction

Overview

This update on cerebellar mutism adds current literature regarding risk factors associated with cerebellar mutism as well as the ongoing efforts to mitigate those risk factors. Longer-term neurocognitive prognosis following the diagnosis of cerebellar mutism is also included.

Key points

	• Cerebellar mutism is not necessarily a transient disease. Although the mutism typically resolves, patients are still likely to chronically have varying degrees of dysarthria, ataxia, and cognitive dysfunction.
	• A consensus statement has defined cerebellar mutism with the intent of clearly identifying and unifying the multiple signs and symptoms that are associated with cerebellar mutism. Specifically, it explicitly cites this disease as being a postoperative consequence in children in the effort to further research and improve the quality of life for these patients.
	• Damage to the dentato-thalamo-cortical fiber tracts and proximal efferent cerebellar pathways are being identified via imaging and metabolic studies in patients with cerebellar mutism.
	• There is still no clear cause for cerebellar mutism. However, bilateral cerebellar damage, brainstem invasion/compression by tumor, and large tumor size are noted as risk factors in multiple papers.
	• Patients with cerebellar mutism exhibit greater short- and long-term neurocognitive impairment that require close follow-up and intervention.

Historical note and terminology

A child’s loss of speech after removal of a cerebellar tumor was initially described in 1958 (21). This complication of posterior fossa surgery was mentioned in the literature in the following decades (44; 92) and became more widely recognized after a landmark case series of six patients in 1985 (87). Since then, the descriptions of hundreds of additional cases have contributed to the understanding of this unique constellation of signs and symptoms that to be known as the posterior fossa or cerebellar mutism syndrome. Cerebellar mutism syndrome is characterized by partially reversible decreased production of speech and often mutism, frequently in association with diffuse cerebellar dysfunction (ataxia and axial hypotonia), and a variety of neurobehavioral affective disturbances consisting of prominent emotional lability with irritability and apathy (44; 92; 116; 87; 110; 08; 25; 32; 36; 70; 94; 16; 42; 23; 74; 05; 10; 55; 03; 20; 84; 108; 49; 62; 93; 13; 38; 48; 60; 107; 15; 27; 100; 37; 47; 111; 65; 103; 78; 79; 90).

Given the multiple names and constellation of symptoms associated with mutism after cerebellar surgery, the Posterior Fossa Society was formed in 2014. The group issued a consensus statement in 2016, which introduced the term “postoperative pediatric cerebellar mutism syndrome” in an effort to unify the literature (40). The core symptom of postoperative pediatric cerebellar mutism syndrome is cerebellar mutism, defined as a transient reduction in speech due to damage to the cerebellum (as opposed to other structures involved in speech production such as the cerebral cortex and cranial nerves). The consensus statement reads: “Post-operative pediatric CMS is characterized by delayed onset mutism/reduced speech and emotional lability after 4th ventricle tumor surgery in children. Additional common features include hypotonia and oropharyngeal dysfunction/dysphagia. It may frequently be accompanied by the cerebellar motor syndrome, cerebellar cognitive affective syndrome and brain stem dysfunction including long tract signs and cranial neuropathies. The mutism is always transient but recovery may not return to normal, and other deficits of cognitive, affective and motor function often persist” (40). For the remainder of this review, we will refer to this syndrome as cerebellar mutism syndrome (or CMS).

Clinical manifestations

Presentation and course

The symptoms of postoperative cerebellar mutism typically have onset 1 to 2 days after posterior fossa surgery (116; 32; 70; 19; 84; 108; 93; 37). Clinical manifestations consist of abnormalities in speech or mutism, neurobehavioral or affective disturbances, diffuse cerebellar dysfunction, long tract findings, and cranial neuropathies.

Speech impairment is characterized by transient decreased production of speech and or complete mutism. When present, speech is limited to single words or short phrases, which are only elicited by repeated prompting. In a prospective cohort study of 60 children with medulloblastoma and postoperative cerebellar mutism undergoing tumor resection, 40 (66%) had complete and 20 (33%) had partial mutism (53). In most cases, receptive language is preserved relative to expressive language, although deficits in comprehension have been reported (109; 49; 93; 48). More language abnormalities associated with the mutism syndrome can go beyond deficient speech and articulation. A pervasive communication deficit, affecting comprehension as well as expressive language, was also noted in a significant number of patients with cerebellar mutism syndrome on comprehensive language evaluation during recovery (100). Speech improved in six of seven children who developed mutism after posterior fossa tumor resection but returned to normal in only one of them (103).

With recovery from cerebellar mutism syndrome, a speech pattern characterized as ataxic dysarthria has been described in a large fraction of patients. A review of 134 cases from the literature reported that 106 patients (79%) had dysarthric speech after resolution of the mutism (37). This finding has led to the hypothesis that the mutism may represent the most severe form of dysarthria, in effect, an ataxic anarthria (108; 107; 15).

Besides the core impairments in speech, cerebellar ataxia is nearly universal in cerebellar mutism syndrome. Some degree of ataxia was present with cerebellar mutism syndrome in 106 of 107 patients with cerebellar mutism syndrome in a multicenter prospective study; the ataxia was reported to be severe in 44% of them (90). This finding was corroborated in a prospective cohort study of 60 children with medulloblastoma and cerebellar mutism syndrome, all of whom had ataxia (53). Apraxia was also common, occurring in 40 (66%) patients. Movement disorders were seen in 28 (16%) of patients and included multifocal myoclonus, focal dystonia, tremor, ballism, and dyskinesias. Ocular abnormalities were seen in 18 (30%) of patients and presented primarily with impaired ocular fixation.

Most patients with cerebellar mutism syndrome exhibit a spectrum of neurobehavioral abnormalities. Substantial emotional lability and irritability is commonly described (116; 18; 109; 84; 100). In one series, an almost stereotypical response with inconsolable shrill whining occurred in 11 of 12 patients (84). Striking apathy and lack of initiative or hypokinesis are also commonly reported (46; 109; 100).

A variety of other neurologic abnormalities have also been noted in patients with cerebellar mutism syndrome. In the absence of bulbar cranial nerve deficits, decreased oral intake or oromotor apraxia has been described (46; 32; 109; 20; 84; 38; 48; 100). Persistent eye closure for prolonged periods, with apparent inability to initiate spontaneous opening of the eyes and usually in the absence of oculomotor deficits, was noted in two series (84; 100). Cerebellar mutism syndrome typically occurs in the absence of significant cranial nerve deficits or long tract signs (70; 31), although pontine cranial nerve deficits (VI or VII) or hemiparesis were found in several series (109; 84; 108; 100). The abrupt onset of visual loss has been reported in association with cerebellar mutism syndrome (22). Transient urinary and fecal incontinence was associated with the syndrome in five of eight patients in one series (100).

Prognosis and complications

Almost all patients with cerebellar mutism syndrome experience resolution of mutism symptoms, although most exhibit residual ataxic dysarthria and other deficits (30; 37). In a case series of 134 patients with cerebellar mutism syndrome reported in the literature, the mutism resolved at a mean of 8 weeks, with a range of 4 days to 5 months (37). A case-control study of children after cerebellar tumor resection demonstrated significantly more long-term residual ataxic dysarthria in those who had suffered cerebellar mutism syndrome than in those who had not (45). A critical review of 283 children with cerebellar mutism syndrome found that 99% displayed ataxic dysarthric motor speech deficits after recovery from the period of being totally mute (24).

Other lingering neurologic sequelae are also common. In a multicenter prospective evaluation of cerebellar mutism syndrome among medulloblastoma patients, persistent ataxia and speech difficulties were present to a moderate or severe degree for as long as 1 year from diagnosis in 66% (ataxia) and 44% (speech) of the patients who were initially judged to have had a severe degree of the syndrome (90). More significant residual speech deficits and a trend toward more ataxia was also seen among the initially most severe of 11 cerebellar mutism syndrome patients in one case series (112). Moreover, intellectual deficits that extend beyond strictly linguistic function have been noted in some patients recovering from cerebellar mutism syndrome. In one series, several of the 12 children recovering from cerebellar mutism syndrome had impairments in recent memory, attention span, problem-solving ability, and executive function on detailed neuropsychometric testing (84). As well, a significant fraction of patients with cerebellar mutism syndrome in the prospective medulloblastoma study were estimated to have persistent mild to moderate deficits of global cognitive function at 1 year from initial diagnosis of their tumors (90).

Persistent psychosocial problems, including obsessive-compulsive disorder, withdrawal behavior, and general difficulties with social interaction, were reported to be significantly more frequent in medulloblastoma patients who had experienced postoperative cerebellar mutism (117). Neurocognitive data available in 12 of 28 children after medulloblastoma tumor resection at a mean of 4.5 years after surgery demonstrated mean IQ to be 16 points lower among the five children with cerebellar mutism syndrome (112). At 1, 3, and 5 years following diagnosis of medulloblastoma, children who were initially diagnosed with posterior fossa syndrome following their treatment for medulloblastoma had lower mean scores on measures of general intellectual ability, processing speed, broad attention, working memory, and spatial relations compared to those without diagnosis of posterior fossa syndrome. Attention and working memory were also noted to decline over time. The posterior fossa syndrome group had mean scores at least one standard deviation below the mean for intellectual ability, processing speed, and broad attention across all time points and for working memory by 5 years postdiagnosis (97).

Clinical vignette

A 6-year-old boy presented to the emergency room with a history of progressive headache, morning vomiting, and unsteadiness of gait that had been getting worse over the previous 2 to 3 weeks. He was also complaining of double vision that was worse on left lateral gaze. On examination, he was mildly lethargic, but mental status was otherwise normal. His visual acuity and fields were normal, but bilateral papilledema was present. He had a partial left sixth nerve palsy and a mild degree of truncal ataxia. On brain MRI, there was a 4 X 3.5 X 3.5 cm homogeneous, gadolinium-enhancing mass arising from the cerebellar vermis and within the fourth ventricle, obstructing its outflow and causing a moderate degree of hydrocephalus.

After placement of an external ventriculostomy, the boy underwent a suboccipital craniotomy and gross total resection of the tumor, which was seen to be adherent to the brainstem. The histopathological tumor diagnosis was medulloblastoma. Disease-staging evaluation revealed no spinal metastases or residual tumor on postoperative MRI, and CSF cytologic examination was negative for neoplastic cells. He was extubated quickly following the surgery and had no new neurologic deficits in the immediate postoperative period.

His headaches resolved, the sixth nerve palsy improved, and he was noted to be speaking normally in short sentences to his parents and nurses. His ventriculostomy was weaned over 5 days, and he did not require shunting.

Then, on the second postoperative day, he stopped talking entirely and became extremely irritable, vocalizing only with frequent whining or high-pitched crying. He appeared to follow some verbal commands but would not always do so during periods of irritability. He did not want to eat and appeared to have difficulty with the initiation of chewing and swallowing, but he had no aspiration of liquids or solids on a swallow study. These symptoms persisted more or less unchanged for 2 to 3 weeks, after which time, he started to speak a few single words and was becoming less irritable.

As his speech gradually improved over the subsequent 2 months while he was undergoing craniospinal irradiation, it became apparent that he had an ataxic dysarthria as well as mild truncal ataxia. After completion of radiation therapy, he began a course of adjuvant chemotherapy. His speech and language comprehension, along with his gait, continued to improve during the chemotherapy, and his parents considered that his speech articulation and content were nearly back to normal by 1 year from diagnosis. There was no evidence of recurrent tumor on routine surveillance imaging. However, on detailed neuropsychometric testing at that time, he was found to have mild deficits of language comprehension, auditory processing, and executive function.

Biological basis

Etiology and pathogenesis

Tumor type and location. Most patients affected by cerebellar mutism syndrome are children who have undergone resection of midline cerebellar or fourth ventricular tumors. In a review of cases of cerebellar mutism, 117 of 134 (89%) had midline posterior fossa tumors, of which 85 (63%) were medulloblastomas, 24 (18%) were astrocytomas, and 19 were ependymomas (14%) (37).

The occurrence of brainstem involvement by tumor was a factor found to significantly correlate with the development of cerebellar mutism syndrome in the Children’s Oncology Group medulloblastoma study (90). Several series have shown an association between brainstem involvement and the development of mutism (32; 109; 84; 64; 85; 98). A metaanalysis of 28 studies involving 2276 pediatric patients identified tumor invasion of the brainstem (OR 4.3, 95% CI 2.2–8.2), fourth ventricle (OR 12.8, 95% CI 4.3–38.4), and superior cerebellar peduncle (OR 6.8, 95% CI 2.4–19.5) as significant risk factors for cerebellar mutism syndrome (83).

Surgical approach. From a review of the operative approach to posterior fossa tumor surgery at a single institution, Dailey and colleagues found a correlation between cerebellar mutism syndrome and splitting the inferior cerebellar vermis, which they postulated as an etiology (20). Indeed, surgical approaches using a vermian incision has been associated with cerebellar mutism and a subsequent low IQ (20; 15; 89; 39; 86). Kellog and Piatt reported a surgical approach to fourth ventricular tumors without splitting the vermis that avoided mutism (52). In another series, no cerebellar mutism syndrome was reported among 16 patients who underwent resection of fourth ventricular tumors by a telovelar surgical approach that avoided splitting vermian structures (29). Further, a combined transventricular and supracerebellar infratentorial approach preserving the vermis avoided the mutism syndrome in four patients with giant posterior fossa tumors that involved the tectum and the 4th ventricle (43).

Cerebellar-cortical connections. The role of the cerebellum extends beyond the motor domain. A spectrum of nonmotor cognitive deficits, some of which are seen in cerebellar mutism syndrome, has been described in patients with a variety of cerebellar diseases or injuries. This has been called cerebellar cognitive affective syndrome and is characterized by disturbances of executive function, visual-spatial disorganization, and nonarticulation language problems, including mild anomia and agrammatism. Personality changes with blunting or disinhibition of affect are also seen (33; 95; 113). In a network analysis of 30 pediatric patients with cerebellar mutism syndrome, lesions involving the vermis and inferomedial cerebellar lobules were associated with disruptions in cerebellothalamocortical circuitry similar to abnormalities seen in patients with autism spectrum disorder (104).

These clinical observations are supported by experimental neuroanatomic studies in primates and by functional imaging in humans, showing cerebellar involvement in extramotor functions. Using a retroviral detector in monkeys, a direct connection was demonstrated between dentate nuclei and the nonmotor prefrontal cortex, a region known to be involved in spatial working memory and future behavior-planning (66). Functional imaging with PET and fMRI methodology showed cerebellar activation in complex human cognitive operations such as puzzle-solving, sensory discrimination, and visual attention in the complete absence of motor activity. Moreover, this localization was in discrete areas of the cerebellum independent of those activated by motor activity (33; 54; 35; 06). A role for the cerebellum in mediating emotional behavior was demonstrated by the alleviation of aggressive behaviors in isolation-reared primates after the production of various cerebellar lesions (82; 12). Functional connections have also been identified between cerebellar and limbic structures, further strengthening a hypothesis that the cerebellum can modulate behavior and emotion (09; 41).

Several investigators have postulated the dentato-thalamo-cortical pathways as the anatomical substrate of cerebellar mutism (25; 19; 34; 84; 30; 58). These pathways project both to and from the dentate nucleus of cerebellum on either side, crossing in the superior and middle cerebellar peduncle, through the brainstem to the contralateral red nucleus and thalamus and on to the premotor and supplementary motor cortex (Adams and Victor 1993; 75). There is evidence that injury anywhere along the dentato-thalamo-cortical pathways can produce mutism. However, the proximal segment of the dentato-thalmo-cortical pathway appears to be clinically most relevant, as tumors and surgical resection occur within the region of this pathway (03; 91; 59). The proximal efferent cerebellar pathway consisting of the dentate nucleus, the superior cerebellar peduncle, and the mesencephalic tegmentum appear to be involved on imaging of patients with cerebellar mutism (109; 84; 113; 69; 86; 67; 75).

Injury of the dentate-thalamo cortical pathway is thought to lead to cerebello-cerebral diaschisis. This causes hypoperfusion and decreased metabolic activity in the corresponding cerebral cortex due to lack of excitatory stimulation from the cerebellum. Perfusion and diffusion tensor imaging studies have demonstrated this connection (38; 91; 69; 67; 102).

Children have become mute after injury to the brainstem, in which the proximal portions of the dentato-thalamo-cortical tracts travel. Mutism has occurred after surgical treatment of a pontine cavernous hemangioma or brainstem tumor (76; 109; 34) or after brainstem stroke (68). Brainstem involvement by tumor correlated with the development of cerebellar mutism syndrome in several series, including the multicenter medulloblastoma study, and could localize dysfunction to the brainstem within the dentato-thalamo-cortical pathways (84; 108; 90). A higher incidence of brainstem tumor invasion was also found in a series of 11 of 28 patients with cerebellar mutism syndrome after medulloblastoma surgery (112). In a prospective case-control study of 26 children, 13 with cerebellar mutism and 13 without cerebellar mutism after posterior fossa surgery, postoperative MRI signal abnormalities were observed more often in the superior cerebellar peduncles and midbrain in children with mutism than in controls (69). On DTI, there was lower fractional anisotropy of water in white matter tracts in bilateral superior cerebellar peduncles and bilateral fornices in the cerebellar mutism cohort, reflecting more interruption of white matter tracts in these areas.

Diffusion abnormalities in the proximal efferent cerebellar pathway have been associated with the development of cerebellar mutism, particularly bilateral involvement of the proximal efferent cerebellar pathway (11). Another group noted bilateral diffusion abnormalities about the surgical cavity and likely involving the dentate nucleus as being a risk factor (17). The superior cerebellar peduncles may also demonstrate abnormalities in diffusion-weighted images as well as on FLAIR in those with cerebellar mutism (106). Hypertrophic olivary degeneration can be demonstrated on MRI in patients with cerebellar mutism. This finding is thought to be caused by denervation injury of Mollaret triangle and further implicates the proximal efferent cerebellar pathways as the causative site of injury (11; 81).

Diffusion tensor imaging (DTI) and tractography map white matter fiber tracts on MRI. Reduced cerebello-thalamo-cortical volumes in postoperative patients with medulloblastomas evaluated via DTI correlated with poorer motor outcomes for patients (73). Other studies utilizing DTI found decreased fiber tract organization (reduced fractional anisotropy) within the bilateral superior cerebellar peduncles that persisted beyond a year post development of cerebellar mutism (75; 63). Decreased fronto-cerebellar association fibers volumes were also seen in patients with cerebellar mutism along with diminished fiber signal from the superior cerebellar peduncles and midline cerebellar structures in patients with cerebellar mutism, suggesting a link for the neurocognitive sequelae seen in patients with cerebellar mutism (102). These clinical observations and imaging data suggest that mutism after posterior fossa tumor surgery could involve dentato-thalamo-cortical pathways and most likely the dentate, superior cerebellar peduncle, and/or brainstem portions.

Wisoff and Epstein postulated that edema developing in supranuclear afferent pathways, caused by intraoperative retraction of these structures, was the pathophysiology of the syndrome (116). This hypothesis could also account for the delayed onset after surgery and partially transient nature of the syndrome, reflecting the time interval for development and regression of edema. The development of delayed edema by this same mechanism, but in the cerebellum itself, was also hypothesized by Ozek and colleagues, who recommended avoidance of constant retraction of bilateral cerebellar structures as a way to prevent the syndrome (76). A retrospective study demonstrated a statistically significant greater degree of preoperative pons compression and greater increase in postoperative pons diameter on MRI in 13 of 51 children who developed cerebellar mutism syndrome after resection of a posterior fossa midline tumor (64). The authors postulated that the greater compression may make white matter tracts in brainstem more vulnerable to injury after surgical manipulation, and that the relatively sudden release of this greater force at surgery may increase predisposition to axonal distortion and injury.

Other mechanisms. Early studies noted that larger posterior fossa tumors were associated with cerebellar mutism syndrome (37). Contrary to this, in several large series, tumor size was not a risk factor for the development of cerebellar mutism syndrome (84; 108; 100; 90; 17; 98).

Tumor presentation with hydrocephalus has been proposed as another mechanism of cerebellar mutism syndrome development. In a series of 134 patients with cerebellar mutism syndrome, 42 (31%) required placement of a ventriculoperitoneal shunt (37). Hydrocephalus that required CSF diversion appeared to be a significant factor in a small series in which five of five patients with cerebellar mutism syndrome, but only four of 10 without cerebellar mutism syndrome required a ventriculoperitoneal shunt (109). In a case of 60 pediatric patients undergoing posterior fossa tumor resection, both hydrocephalus at presentation and in the postoperative period were significantly associated with the development of cerebellar mutism syndrome (96).

A prospective Italian study found that abnormal language prior to surgery was a strong risk factor for the development of cerebellar mutism (26). All seven of 34 children who developed cerebellar mutism (20%) after posterior fossa tumor surgery had preoperative language impairment; no child with normal preoperative language developed mutism.

Postoperative vasospasm causing ischemia also has been proposed as a mechanism of injury that could account for the period of latency before the onset of symptoms (32; 70). On a SPECT scan, hypoperfusion was detected in the cerebellar hemisphere in a patient with mutism and then normalized after resolution of the mutism (30). The bilateral edema in middle cerebellar peduncles in many of the patients with cerebellar mutism syndrome was thought to be consistent with ischemia from vasospasm in these structures as a pathophysiologic mechanism of cerebellar mutism syndrome (84). Sagiuchi reported decreased blood flow in both cerebellar hemispheres (as well as in both thalami and frontal lobes) on SPECT scan after resection of a right cerebellar hemispheric medulloblastoma. This normalized after improvement of the patient’s mutism, providing support for a mechanism of delayed edema or ischemia in the cerebellum as a cause of cerebellar mutism syndrome (91). The hypoperfusion in the thalami and frontal lobes provides support for cerebellar connections to these structures, which are known to undergo changes in perfusion and metabolism with changes in the metabolism of the contralateral cerebellar hemisphere (91).

Prevention

Based on the hypothesis that incision or removal of the cerebellar vermis was a cause of cerebellar mutism syndrome, it has been proposed that an approach that avoided splitting the vermis could avoid mutism (20; 52; El–Bahy 2005). However, such an approach does not appear to prevent cerebellar mutism syndrome with any consistency (23; 84; 100; 119). The avoidance of prolonged intraoperative retraction was proposed as a means of preventing cerebellar mutism syndrome in view of the hypothesis that this might be a factor contributing to cerebellar mutism syndrome by producing delayed postoperative edema or ischemia in cerebellar or pericerebellar structures (116; 76). But avoidance of prolonged intraoperative retraction has not been shown to be effective in preventing cerebellar mutism syndrome. Better understanding of the pathophysiology of postoperative mutism is needed to reduce the incidence of this postoperative complication in the future.

A multicenter international retrospective study evaluated modifiable factors associated with the development of cerebellar mutism in children with resection of posterior fossa tumors; however, no significant associations were seen with preresection surgical hydrocephalus treatment, prone position, ultrasonic aspirator use, external ventricular drain use, cerebellar vermis sparing approach, complete or near total resection, or treating center with postoperative cerebellar mutism (88). Another group found along with brainstem invasion and/or compression that an increase of 0.5 degrees Celsius in mean body temperature in the first 4 postoperative days resulted in an almost 5-fold increased odds ratio of developing cerebellar mutism (85).

An imaging-based preoperative risk scoring system to stratify patients in terms of postoperative cerebellar mutism risk has been developed (61). Using the six identified predictors of primary location, bilateral middle cerebellar peduncle involvement, dentate nucleus invasion, and age at imaging of more than 12.4 years, patients were risk stratified into low, intermediate, and high risk of cerebellar mutism, with 88.8% accuracy. This process allows for preoperative risk stratification during surgical consent. Additionally, use of intraoperative imaging significantly reduced cerebellar mutism syndrome risk (OR 0.36, 95% CI 0.18–0.72) in a large metaanalysis of 28 studies (83).

Management

The comprehensive characterization of the neurologic impairments seen in cerebellar mutism syndrome may include severe communication deficits of expressive and sometimes receptive language with evolution to dystaxic speech, severe global cerebellar dysfunction, emotional lability, and sometimes inattention, oromotor dyspraxia, and loss of bowel and bladder control. This rather global picture of neurologic dysfunction frequently necessitates an intensive program of rehabilitation that includes speech, occupational, and physical therapy for patients recovering from cerebellar mutism syndrome. One reported case described a child who developed cerebellar mutism syndrome with complete absence of speech for 2 weeks after resection of a posterior fossa tumor; but the child was abruptly able to sing along with a musical video, which seemed to trigger a rapid and sustained overall speech recovery (77). The nonbenzodiazepine hypnotic agent, zolpidem, is primarily used as a sedative, but there is some evidence for its efficacy in alleviating mutism and akinesia in other neurologic and psychiatric disorders. Zolpidem was reported to have increased arousal and accelerated recovery of speech via an uncertain mechanism in a child with postoperative cerebellar mutism (99). Another case report reported the resolution and recurrence of cerebellar mutism correlating with the administration and clearance of midazolam in one patient; the authors performed SPECT analysis on this patient’s brain and also demonstrated initially reduced blood flow to cerebral cortex that resolved on follow-up (71).

There is little experience with pharmacological management of the symptoms of cerebellar mutism syndrome. High-dose steroids were administered to several patients with cerebellar mutism syndrome with a thought to preventing the edema hypothesized as a cause of the syndrome, either from intraoperative retraction of cerebellar structures or from postoperative vasospasm; they were ineffective in reversing the symptoms (84). However, two children with postoperative cerebellar mutism syndrome were reported to have had accelerated improvement after treatment with fluoxetine, a serotonin-reuptake inhibitor antidepressant medication. This idea for therapy was based on the hypothesis that speech and language impairment in childhood autism is related to decreased serotonin in the cerebral cortex, resulting from interruption of the dentato-thalamo-cortical pathways. A subsequent case report of a child with cerebellar mutism responding to fluoxetine was published in 2012 (04). A patient who developed cerebellar mutism syndrome after resection of a low-grade fourth ventricular neuronal-glial tumor was reported to have improved dramatically with the administration of bromocriptine. This was hypothesized to have restored possible decreased brainstem dopaminergic outflow related to the mutism (01).

Outcomes

Despite the age of injury and the number of years after surgery, most patients were found to have made their most substantial improvements within the first year of cerebellar mutism (45; 105). However, most patients with postoperative cerebellar mutism go on to have some speech difficulties (103). Patients with tumors requiring only surgical resection and without brainstem invasion may have a favorable prognosis in one study (105). The same group found that patients presenting at diagnosis with associated combined procedural memory and defective neurocognitive function tend to have a more severe cerebellar mutism course and are less prone to complete recovery.

Additionally, the emotional toll that these deficits may cause or may be a direct consequence of cerebellar injury needs to be monitored with referral to a psychologist/psychiatrist, as needed. Patients should be referred for rehabilitation services focusing on speech and any other associated cerebellar/cranial nerve findings along with neurocognitive assessment and rehabilitation. These patients will likely need individualized education plans at school.

References

01: Adachi J, Nishikawa R, Hirose T, Matsutani M. Mixed neuronal-glial tumor of the fourth ventricle and successful treatment of postoperative mutism with bromocriptine: case report. Surg Neurol 2005;63:375-9. PMID 15808729
02: Adams RD, Victor M. The cerebellum. In Adams RD, Victor M, editors. Principles of neurology, 5th ed. New York: McGraw-Hill;1993:74-82.
03: Aguiar PH, Plese JP, Ciqini O, Marino R Jr. Transient mutism following a posterior fossa approach to cerebellar tumors in children: a critical review of the literature. Childs Nerv Syst 1995;11:306-10. PMID 7648574
04: Akhaddar A, Salami M, El Asri AC, Boucetta M. Treatment of postoperative cerebellar mutism with fluoxetine. Childs Nerv Syst 2012;28(4):507-8. PMID 22349903
05: Al-Jarallah A, Cook JD, Gascon G, Kanaan I, Sigueira E. Transient mutism following posterior fossa surgery in children. J Surg Oncol 1994;55:126-31. PMID 8121185
06: Allen G, Buxton RB, Wong EC, Courchesne E. Attentional activation of the cerebellum independent of motor involvement. Science 1997;275:1940-3. PMID 9072973
07: Altshuler LL, Cummings JL, Mills MJ. Mutism: review, differential diagnosis and report of 22 cases. Am J Psychiatry 1986;143:1409-14. PMID 3777229
08: Ammirati M, Mirzai S, Samii M. Transient mutism following resection of a cerebellar tumour: a case report and review of the literature. Child Nerv Syst 1989;5:12-4.
09: Anand BK, Malhotra CL, Singh B, Dua S. Cerebellar projections to limbic system. J Neurophysiol 1959;22:451-8. PMID 13673296
10: Asamoto M, Ito H, Suyuki N, Oiwa Y, Saito K, Haroka J. Transient mutism after posterior fossa surgery. Child Nerv Syst 1994;10:273-8.
11: Avula S, Kumar R, Pizer B, et al. Diffusion abnormalities on intraoperative magnetic resonance imaging as an early predictor for the risk of posterior fossa syndrome. Neuro Oncol 2015;17(4):614-22. PMID 25319997
12: Berman AJ, Berman D, Prescott JW. The effect of cerebellar lesions on emotional behavior in the rhesus monkey. In: Cooper IS, Riklan M, Snider RS, editors. The cerebellum, epilepsy and behavior. New York: Plenum Press, 1978:277-84.
13: Bhatoe HS. Mutism: oropharyngeal apraxia and dysarthria after posterior fossa tumour excision. Br J Neurosurg 1997;11:341-3. PMID 9337934
14: Cakir Y, Karakisi D, Kocanaogullari O. Cerebellar mutism in an adult: case report. Surg Neurol 1994;41(4):342-4. PMID 8165509
15: Catsman-Berrevoets CE, Van Dongen HR, Mulder PG, Paz y Geuze D, Paquier PF, Lequin MH. Tumour type and size are high risk factors for the syndrome of cerebellar mutism and subsequent dysarthria. J Neurol Neurosurg Psychiatry 1999;67(6):755-7. PMID 10567492
16: Catsman-Berrevoets CE, Van Dongen HR, Zwetsloot CP. Transient loss of speech followed by dysarthria after removal of posterior fossa tumor. Dev Med Child Neurol 1992;34:1102-9. PMID 1451941
17: Chua FHZ, Thien A2, Ng LP, et al. Post-operative diffusion weighted imaging as a predictor of posterior fossa syndrome permanence in paediatric medulloblastoma. Childs Nerv Syst 2017;33(3):457-65. PMID 28190209
18: Cochrane DD, Gustavsson B, Poskitt KP, Steinbok P, Kestle JR. The surgical and natural morbidity of aggressive resection of the posterior fossa in childhood. Pediatr Neurosurg 1994;20:19-29. PMID 8142278
19: Crutchfield JS, Sawaya R, Meyers CA, Moore BP 3rd. Postoperative mutism in neurosurgery: report of two cases. J Neurosurg 1994;89:115-21. PMID 8207512
20: Dailey AT, McKhann GM 2nd, Berger MS. The pathophysiology of oral pharyngeal apraxia and mutism following posterior fossa tumor resection in children. J Neurosurg 1995;83:467-75. PMID 7666224
21: Daly DD, Love JG. Akinetic mutism. Neurology 1958;8(3):238-42. PMID 13517492
22: Daniels SR, Moores LE, DiFazio MP. Visual disturbance associated with postoperative cerebellar mutism. Ped Neurol 2005;32:127-30. PMID 15664775
23: D’Avanzo R, Scuotto A, Natale M, Scotto P, Cioffi FA. Transient cerebellar mutism in lesion of the mesencephalic-cerebellar region. Acta Neurol (Napoli) 1994;15:289-96.
24: De Smet HJ, Baillieux H, Catsman-Berrevoets C, De Deyn PP, Marien P, Paquier P. Postoperative motor speech production in children with the syndrome of ‘cerebellar’ mutism and subsequent dysarthria: a critical review of the literature. Eur J Ped Neurol 2007;11:193-207. PMID 17320435
25: Dietze DD Jr, Mickle JP. Cerebellar mutism after posterior fossa surgery. Pediatr Neurosurg 1990;16:25-31. PMID 2133406
26: Di Rocco C, Chieffo D, Frassanito P, Caldarelli M, Massimi L, Tamburrini G. Heralding cerebellar mutism: evidence for pre-surgical language impairment as primary risk factor in posterior fossa surgery. Cerebellum 2011;10(3):551-62. PMID 21476131
27: Doxey D, Bruce D, Sklar F, Swift D, Shapiro K. Posterior fossa syndrome: identifiable risk factors and irreversible complications. Pediatr Neurosurg 1999;31:131-6. PMID 10708354
28: Dunwoody GW, Alsagoff ZS, Yuan SY. Cerebellar mutism with subsequent dysarthria in an adult: case report. Br J Neurosurg 1997;11:161-3. PMID 9156007
29: El-Bahy K. Telovelar approach to the fourth ventricle: operative findings and results in 16 cases. Acta Neurochir (Wien) 2005;147(2):137-42. PMID 15605202
30: Ersahin Y, Mutluer S, Cagli S, Duman Y. Cerebellar mutism: report of seven cases and review of the literature. Neurosurgery 1996;38:60-6. PMID 8747952
31: Ersahin Y, Saffet M, Selcuk S, Barcin E. Cerebellar mutism: report of two unusual cases and review of the literature. Clin Neurol Neurosurg 1997;99:130-4. PMID 9213058
32: Ferrante L, Mastronardi L, Acqui M, Fortuna A. Mutism after posterior fossa surgery in children: report of 3 cases. J Neurosurg 1990;72:959-63. PMID 2187060
33: Fiez JA, Peterson SE, Cheney MK, Raichle ME. Impaired non-motor learning and error detection associated with cerebellar damage: a single case study. Brain 1992;115:155-78. PMID 1559151
34: Frim DM, Ogilvy CS. Mutism and cerebellar dysarthria after brain surgery: case report. Neurosurgery 1995;36:854-7. PMID 7596521
35: Gao JH, Parson LM, Bower JM, Xiong J, Li J, Fos PT. Cerebellum implicated in sensory acquisition and discrimination rather than motor control. Science 1996;272:545-7. PMID 8614803
36: Gaskill S, Martin A. Transient eye closure after posterior fossa tumor surgery in children. Ped Neurosurg 1991;17:196-8. PMID 1822134
37: Gelabert-Gonzalez M, Fernandez-Villa J. Mutism after posterior fossa surgery: review of the literature. Clin Neurol Neurosurg 2001;103:111-4. PMID 11516555
38: Germano A, Baldari S, Caruso G, et al. Reversible cerebral perfusion alterations in children with transient mutism after posterior fossa surgery. Childs Nerv Syst 1998;14:114-9. PMID 9579866
39: Grill J, Viguier D, Kieffer V, et al. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. J Neurosurg 2004;101(2 Suppl):152-8. PMID 15835102
40: Gudrunardottir T, Morgan AT, Lux AL, et al. Consensus paper on post-operative pediatric cerebellar mutism syndrome: the Iceland Delphi results. Childs Nerv Syst 2016;32(7):1195-203. PMID 27142103
41: Heath RG. Electroencephalographic studies in isolation-reared monkeys with behavioral impairment. Dis Nerv Syst 1972;33:157-63. PMID 4623343
42: Herb E, Thyen U. Mutism after cerebellar medulloblastoma surgery. Neuropaediatrics 1992;23:144-6. PMID 1641081
43: Hermann EJ, Rittierodt M, Krauss JK. Combined transventricular and supracerebellar infratentorial approach preserving the vermis in giant pediatric posterior fossa midline tumors. Operative Neurosurg 2008;63:30-7.
44: Hirsch JF, Renier D, Czernichow P, Benveniste L, Pierre-Kahn A. Medulloblastoma in childhood: survival and functional results. Acta Neurochir (Wien) 1979;48:1-15. PMID 495234
45: Huber JF, Bradley K, Spiegler BJ, Dennis M. Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood. Childs Nerv Syst 2006;22(2):132-8. PMID 16155765
46: Humphreys RP. Mutism after posterior fossa surgery. In: Marlin AE, editor. Concepts of pediatric neurosurgery. Vol 9. Basel: Karger, 1989:57-64.
47: Ildan F, Tuna M, Erman T, Gocer AI, Zeren M, Cetinalp E. The evaluation and comparison of cerebellar mutism in children and adults after posterior fossa surgery: report of two adult cases and review of the literature. Acta Neurochir (Wien) 2002;144:463-73. PMID 12111502
48: Janssen G, Messing-Junger AM, Engelbrecht V, Gobel U, Bock WJ, Lenard HG. Cerebellar mutism syndrome. Klinische Padiatrie 1998;210:243-7. PMID 9743960
49: Jones S, Kirollos RW, van Hille PT. Cerebellar mutism following posterior fossa tumour surgery. Br J Neurosurg 1996;10:221-4. PMID 8861318
50: Kai Y, Kuratsu J, Suginohara K, Marubayashi T, Ushio Y. Cerebellar mutism after posterior fossa surgery: two case reports. Neurol Med Chir (Tokyo) 1997;37:929-33. PMID 9465594
51: Kawai H, Ohta F, Matsumoto Y, Yamamoto Y. An adult case of cerebellar mutism after removal of a cerebellar hematoma. Brain Nerve 2001;53:475-9. PMID 11424360
52: Kellog JX, Piatt JH Jr. Resection of fourth ventricle tumors without splitting the vermis: the cerebellomedullary fissure approach. Pediatr Neurosurg 1997;27:28-33.
53: Khan RB, Patay Z, Klimo P, et al. Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study. Neuro Oncol 2021;23(9):1586-96. PMID 33823018
54: Kim S, Urgurbil K, Strick P. Activation of a cerebellar output nucleus during cognitive processing. Science 1994;265:949-51. PMID 8052851
55: Kingma A, Mooij JJ, Metzemaekers JD, Leeuw JA. Transient mutism and speech disorders after posterior fossa surgery in children with brain tumours. Acta Neurochir 1994;131:74-9. PMID 7709788
56: Koh S, Turkel SB, Baram TZ. Cerebellar mutism in children: report of six cases and potential mechanisms. Pediatric Neurol 1997;16:218-9.
57: Korah MP, Esiashvili N, Mazewski CM, et al. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma. Int J Radiat Oncol Biol Phys 2010;77(1):106-12. PMID 19695790
58: Kusano Y, Tanaka Y, Takasuna H, et al. Transient cerebellar mutism caused by bilateral damage to the dentate nuclei after the second posterior fossa surgery. Case report. J Neurosurg 2006;104(2):329-31. PMID 16509510
59: Law N, Greenberg M, Bouffet E, et al. Clinical and neuroanatomical predictors of cerebellar mutism syndrome. Neuro Oncol 2012;14(10):1294-303. PMID 22952198
60: Liu GT, Phillips PC, Molloy PT, et al. Visual impairment associated with mutism after posterior fossa surgery in children. Neurosurgery 1998;42:253-7. PMID 9482175
61: Liu JF, Dineen RA, Avula S, et al. Development of a pre-operative scoring system for predicting risk of post-operative paediatric cerebellar mutism syndrome. Br J Neurosurg 2018;32(1):18-27. PMID 29433337
62: Mastronardi L. Mutism and pseudobulbar symptoms after resection of posterior fossa tumours in children: incidence and pathophysiology and transient cerebellar mutism after posterior fossa surgery in children. Neurosurgery 1996;38:1066. PMID 8727837
63: McEvoy SD, Lee A, Poliakov A. Longitudinal cerebellar diffusion tensor imaging changes in posterior fossa syndrome. Neuroimage Clin 2016;12:582-90. PMID 27689022
64: McMillan HJ, Keene KL Matzinger MA, Vassilyadi M, Nzau M, Ventureyra EC. Brainstem compression: a predictor of postoperative cerebellar mutism. Childs Nerv Syst 2009;25(6):677-81. PMID 19082829
65: Mewasingh LD, Kadhim H, Christophe C, Christiaens FJ, Dan B. Nonsurgical cerebellar mutism (anarthria) in two children. Ped Neurol 2003;28:59-63.
66: Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science 1994;226:458-61. PMID 7939688
67: Miller NG, Reddick WE, Kocak M, et al. Cerebellocerebral diaschisis is the likely mechanism of postsurgical posterior fossa syndrome in pediatric patients with midline cerebellar tumors. AJNR Am J Neuroradiol 2010;31(2):288-94. PMID 19797787
68: Miyakita Y, Taguchi Y, Sakakibara Y, Matsuzawa M, Kitagawa H. Transient mutism resolving into cerebellar speech after brain stem infarction following a traumatic injury of the vertebral artery in a child. Acta Neurochir 1999;141:209-13. PMID 10189505
69: Morris EB, Phillips HS, Lanningham FH, et al. Proximal dentatothalamocortical tract involvement in posterior fossa syndrome. Brain 2009;132(Pt 11):3087-95. PMID 19805491
70: Nagatani K, Waga S, Nakagawa T. Mutism after removal of vermian medulloblastoma: cerebellar mutism. Surg Neurol 1991;36:307-9. PMID 1948632
71: Nicita F, Paiano M, Liberatore M, et al. Sudden benzodiazepine-induced resolution of post-operative pediatric cerebellar mutism syndrome: a clinical-SPECT study. Acta Neurochir (Wien) 2017;159(3):475-9. PMID 28050719
72: Nishikawa M, Komiyama M, Sakamoto H, Yasui T, Nakajima H. Cerebellar mutism after basilar artery occlusion. Neurol Med Chir (Tokyo) 1998;38:569-73. PMID 9805903
73: Oh ME, Driever PH, Khajuria RK, et al. DTI fiber tractography of cerebro-cerebellar pathways and clinical evaluation of ataxia in childhood posterior fossa tumor survivors. J Neurooncol 2017;131(2):267-76. PMID 27785688
74: Oiwa Y, Ito H, Suzuki N, Otsubo Y. Cerebellar mutism after posterior fossa surgery. Childs Nerv Syst 1993;9:363A.
75: Ojemann JG, Partridge SC, Poliakov AV, et al. Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome. Childs Nerv Syst 2013;29(11):2071-7. PMID 23817992
76: Ozek M, Pamir N, Alptekin B. Mutism after total removal of an exophytic pontine glioma. Turk Neurosurg 1993;3:37-9.
77: Ozgur BM, Berberian J, Aryan HE, Meltzer HE, Levy ML. The pathophysiologic mechanism of cerebellar mutism. Surg Neurol 2006;66(1):18-25. PMID 16793430
78: Ozimek A, Richter S, Hein-Kropp C, et al. Cerebellar mutism—report of four cases. J Neurol 2004;251:963-72. PMID 15316801
79: Papavasiliou AS, Kotsalis C, Trakadas S. Transient cerebellar mutism in the course of acute cerebellitis. Ped Neurol 2004;30:71-4. PMID 14738957
80: Parrish JB, Weinstock-Guttman B, Yeh EA. Cerebellar mutism in pediatric acute disseminated encephalomyelitis. Pediatr Neurol 2010;42(4):259-66. PMID 20304329
81: Patay Z. Postoperative posterior fossa syndrome: unraveling the etiology and underlying pathophysiology by using magnetic resonance imaging. Childs Nerv Syst 2015;31(10):1853-8. PMID 26143277
82: Peters M, Monjan AA. Behavior after cerebellar lesions in cats and monkeys. Physiol Behav 1971;6:205-6. PMID 5001497
83: Pettersson SD, Kitlinski M, Miekisiak G, Ali S, Krakowiak M, Szmuda T. Risk factors for postoperative cerebellar mutism syndrome in pediatric patients: a systematic review and meta-analysis. J Neurosurg Pediatr 2022;29(4):467-75. PMID 34972081
84: Pollack IF, Polinko P, Albright AL, Towbin R, Fitz C. Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery 1995;37:885-93. PMID 8559336
85: Pols SYCV, van Veelen MLC, Aarsen FK, Gonzalez Candel A, Catsman-Berrevoets CE. Risk factors for development of postoperative cerebellar mutism syndrome in children after medulloblastoma surgery. J Neurosurg Pediatr 2017:1-7. PMID 28498095
86: Puget S, Boddaert N, Viguier D, et al. Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors. Cancer 2009;115(6):1338-47. PMID 19195041
87: Rekate HL, Grubb RL, Aram DM, Hahn JF, Ratcheson RA. Muteness of cerebellar origin. Arch Neurol 1985;42:697-8. PMID 4015467
88: Renne B, Radic J, Agrawal D, et al. Cerebellar mutism after posterior fossa tumor resection in children: a multicenter international retrospective study to determine possible modifiable factors. Childs Nerv Syst 2019. [Epub ahead of print] PMID 30659354
89: Riva D, Giorgi C. The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours. Brain 2000;123(Pt 5):1051-61. PMID 10775549
90: Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children’s Oncology Group. J Neurosurg 2006;105(6 Suppl):444-51. PMID 17184075
91: Sagiuchi T, Ishii K, Aoki Y, et al. Bilateral crossed cerebello-cerebral diaschisis and mutism after surgery for cerebellar medulloblastoma. Ann Nuc Med 2001;15:157-60. PMID 11448076
92: Sakai H, Sekino H, Nakamura N. Three cases of "cerebellar mutism." Shinkeinaika 1980;12:302-4.
93: Salvati M, Cervoni L, Santoro A. Cerebellar mutism after posterior cranial fossa surgery. J Neurosurg Sci 1996;40:59-63. PMID 8913962
94: Salvati M, Missori P, Lunardi P, Orlando ER. Transient cerebellar mutism after posterior cranial fossa surgery in an adult. Case report and review of the literature. Clin Neurol Neurosurg 1991;93:313-6. PMID 1665764
95: Schmahmann JD, Sherman JC. The cerebellum and cognition. In: Bradley RJ, Harris RA, Jenner P, editors. International Review of Neurobiology. Vol 41. San Diego: Academic Press, 1997:433-40.
96: Schmidt S, Kovacs E, Usta D, et al. Cerebellar mutism syndrome after posterior fossa tumor surgery in children-a retrospective single-center study. World Neurosurg 2023;173:e622-8. PMID 36871657
97: Schreiber JE, Palmer SL, Conklin HM, et al. Posteriof fossa syndrome and long-term neuropsychological outcomes among children for medulloblastoma on a multi-institutional, prospective study. Neuro Oncol 2017;19(12):1673-82. PMID 29016818
98: Sergeant A, Kameda-Smith MM, Manoranjan B, et al. Analysis of surgical and MRI factors associated with cerebellar mutism. J Neurooncol 2017;133(3):539-52. PMID 28527006
99: Shyu C, Burke K, Souweidane MM, et al. Novel use of zolpidem in cerebellar mutism syndrome. J Pediatr Hematol Oncol 2011;33(2):148-9. PMID 21285896
100: Siffert J, Poussaint TY, Goumnerova LC, et al. Neurological dysfunction associated with postoperative cerebellar mutism. J Neurooncol 2000;48:75-81. PMID 11026700
101: Sinha AK, Rajender Y, Dinakar I. Transient cerebellar mutism after evacuation of a spontaneous vermian haematoma. Childs Nerv Syst 1998;14:460-2. PMID 9808255
102: Soelva V, Hernáiz Driever P, Abbushi A, et al. Fronto-cerebellar fiber tractography in pediatric patients following posterior fossa tumor surgery. Childs Nerv Syst 2013;29(4):597-607. PMID 23184224
103: Steinbok P, Cochrane DD, Perrin R, Price A. Mutism after posterior fossa tumour resection in children: incomplete recovery on long-term follow-up. Ped Neurosurg 2003;39:179-83. PMID 12944697
104: Suresh H, Morgan BR, Mithani K, et al. Postoperative cerebellar mutism syndrome is an acquired Autism-like network disturbance. Neuro Oncol 2023;173:e622-8. PMID 36871657
105: Tamburrini G, Frassanito P, Chieffo D, Massimi L, Caldarelli M, Di Rocco C. Cerebellar mutism. Childs Nerv Syst 2015;31(10):1841-51. PMID 26351234
106: Toescu S, Hettige S, Phipps K, et al. Post-operative paediatric cerebellar mutism syndrome: time to move beyond structural MRI. Childs Nerv Syst 2018;34(11):2249-57. PMID 29926177
107: Turgut M. Transient “cerebellar” mutism. Childs Nerv Syst 1998;14:161-6. PMID 9660116
108: van Calenbergh F, van de Laar A, Plets C, Goffin J, Casaer P. Transient cerebellar mutism after posterior fossa surgery in children. Neurosurgery 1995;37:894-8. PMID 8559337
109: van Dongen HR, Catsman-Berrevoets CE, van Mourik M. The syndrome of “cerebellar“ mutism and subsequent dysarthria. Neurology 1994;44:2040-6. PMID 7969956
110: Volcan I, Cole GP, Johnston K. A case of muteness of cerebellar origin. Arch Neurol 43:313-314, 1986. PMID 3954610
111: Wang MC, Winston KR, Breeze RE. Cerebellar mutism associated with a midbrain cavernous malformation: case report and review of the literature. J Neurosurg 2002;96:607-10. PMID 11883849
112: Wells EM, Khademian ZP, Walsh KS, et al. Postoperative cerebellar mutism syndrome following treatment of medulloblastoma: neuroradiographic features and origin. J Neurosurg Pediatr 2010;5(4):329-34. PMID 20367335
113: Wells EM, Walsh KS, Khademian ZP, Keating RF, Packer RJ. The cerebellar mutism syndrome and its relation to cerebellar cognitive function and the cerebellar cognitive affective disorder. Dev Disabil Res Rev 2008;14:221-8. PMID 18924161
114: Wilbroe M, Cappelen J, Castor C, et al. Cerebellar mutism syndrome in children with brain tumours of the posterior fossa. BMC Cancer 2017;17(1):439. PMID 28637445
115: Wilbroe M, Rochat P, Juhler M. Cerebellar mutism syndrome and other complications after surgery in the posterior fossa in adults: a prospective study. World Neurosurg 2018;110:e738-46. PMID 29180084
116: Wisoff JH, Epstein FJ. Pseudobulbar palsy after posterior fossa operation in children. Neurosurgery 1984;15:707-9. PMID 6504288
117: Wolfe-Christensen C, Mullins LL, Scott JG, McNall-Knapp RY. Persistent psychosocial problems in children who develop posterior fossa syndrome after medulloblastoma resection. Pediatr Blood Cancer 2007;49:723-26. PMID 17066468
118: Yokota H, Nakazawa S, Kobayashi S, Taniguchi Y, Yukihide T. Clinical study of two cases of traumatic cerebellar injury. No Shinkei Geka Neurol Surg 1990;18:67-70. PMID 2406638
119: Zaheer SN, Wood M. Experiences with the telovelar approach to fourth ventricular tumors in children. Pediatr Neurosurg 2010;46(5):340-3. PMID 21346396

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Benjamin I Siegel MD

Dr. Siegel of Emory University School of Medicine has no relevant financial relationships to disclose.
See Profile

Editor

Roger J Packer MD

Dr. Packer of Children’s National Medical Center and George Washington University has no relevant financial relationships to disclose.
See Profile

Former Authors

Patricia L Robertson MD
Karin M Muraszko MD
Kevin C De Braganca MD
Aimee A Sato MD

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: male>female, >1:1
Heredity: none
Population groups selectively affected: none
Occupation groups selectively affected: none

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Cerebellar mutism syndrome

Associated Disorders

Ataxia
Ataxic dysarthria
Dysarthria
Dysmetria
Hypotonia
- Medulloblastoma

Differential Diagnosis

cranial nerve palsies
postoperative bulbar cranial nerve deficits
deficits of facial nerve function
deficits of bulbar cranial nerves
deficits of hypoglossal nerve function
- elective mutism due to psychological or psychiatric causes

Also Relevant

Brainstem gliomas in childhood
Cerebellar astrocytoma
Disorders of articulation
Ependymoma
Medulloblastoma

Clinical Categories

Patient Handouts

Nerve disease and bladder control

Cerebellar mutism syndrome …

Cerebellar mutism syndrome

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Nystagmus

Third nerve palsy

Brain death/death by neurologic criteria

Cerebellar mutism syndrome

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

NF2-related schwannomatosis

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Nystagmus

Third nerve palsy

Brain death/death by neurologic criteria

This is an article preview.
Start a Free Account
to access the full version.